Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Increase Access To MedTech: AdvaMed’s Priorities For The 118th Congress

Executive Summary

AdvaMed’s Medical Innovation Agenda for the 118th Congress emphasizes increased access to medical devices, from reimbursement for breakthrough devices to boosting America’s start-ups to closing the care disparities for underserved communities.

You may also be interested in...



Stack Of New And Revised EU MDR and IVDR Guidances In The Pipeline

The EU has published a lengthy list of new guidances to be drafted as well as existing guidance documents that need updating in the context of its MDR and IVD medtech regulations, including covering the interpretation of the Medical Device Regulation wording on “significant changes.”

FDA FY 2024 Budget Includes 10% Funding Boost, But No Movement On Diagnostics

The FDA requested a 10% increase in budget authority for FY 2024, but diagnostic reform was left out of the proposal. 

What Can Tech Companies Teach Us About Clinical Trials?

Collaboration between tech companies and medical researchers may be the answer to modernizing clinical trials. 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147725

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel